Cargando…

Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)

Detalles Bibliográficos
Autores principales: Chen, Jun, Shen, Tian, Li, Jianhui, Ling, Sunbin, Yang, Zhe, Wang, Guoying, Sun, Liying, Yang, Zhaoxu, Zhuang, Li, Gao, Jie, Guo, Wenyuan, Li, Jie, Xu, Shengjun, Wei, Qiang, Zheng, Shusen, Xu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106222/
https://www.ncbi.nlm.nih.gov/pubmed/36602405
http://dx.doi.org/10.1097/CM9.0000000000002515
_version_ 1785026382925922304
author Chen, Jun
Shen, Tian
Li, Jianhui
Ling, Sunbin
Yang, Zhe
Wang, Guoying
Sun, Liying
Yang, Zhaoxu
Zhuang, Li
Gao, Jie
Guo, Wenyuan
Li, Jie
Xu, Shengjun
Wei, Qiang
Zheng, Shusen
Xu, Xiao
author_facet Chen, Jun
Shen, Tian
Li, Jianhui
Ling, Sunbin
Yang, Zhe
Wang, Guoying
Sun, Liying
Yang, Zhaoxu
Zhuang, Li
Gao, Jie
Guo, Wenyuan
Li, Jie
Xu, Shengjun
Wei, Qiang
Zheng, Shusen
Xu, Xiao
author_sort Chen, Jun
collection PubMed
description
format Online
Article
Text
id pubmed-10106222
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101062222023-04-17 Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition) Chen, Jun Shen, Tian Li, Jianhui Ling, Sunbin Yang, Zhe Wang, Guoying Sun, Liying Yang, Zhaoxu Zhuang, Li Gao, Jie Guo, Wenyuan Li, Jie Xu, Shengjun Wei, Qiang Zheng, Shusen Xu, Xiao Chin Med J (Engl) Consensus Statement Lippincott Williams & Wilkins 2022-12-20 2023-01-05 /pmc/articles/PMC10106222/ /pubmed/36602405 http://dx.doi.org/10.1097/CM9.0000000000002515 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Consensus Statement
Chen, Jun
Shen, Tian
Li, Jianhui
Ling, Sunbin
Yang, Zhe
Wang, Guoying
Sun, Liying
Yang, Zhaoxu
Zhuang, Li
Gao, Jie
Guo, Wenyuan
Li, Jie
Xu, Shengjun
Wei, Qiang
Zheng, Shusen
Xu, Xiao
Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)
title Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)
title_full Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)
title_fullStr Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)
title_full_unstemmed Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)
title_short Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)
title_sort clinical practice guideline on liver transplantation for hepatocellular carcinoma in china (2021 edition)
topic Consensus Statement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106222/
https://www.ncbi.nlm.nih.gov/pubmed/36602405
http://dx.doi.org/10.1097/CM9.0000000000002515
work_keys_str_mv AT chenjun clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT shentian clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT lijianhui clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT lingsunbin clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT yangzhe clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT wangguoying clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT sunliying clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT yangzhaoxu clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT zhuangli clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT gaojie clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT guowenyuan clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT lijie clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT xushengjun clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT weiqiang clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT zhengshusen clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition
AT xuxiao clinicalpracticeguidelineonlivertransplantationforhepatocellularcarcinomainchina2021edition